Form 8-K - Current report:
SEC Accession No. 0001193125-26-253435
Filing Date
2026-06-02
Accepted
2026-06-02 16:01:13
Documents
11
Period of Report
2026-05-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d33725d8k.htm   iXBRL 8-K 31541
  Complete submission text file 0001193125-26-253435.txt   146212

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tyra-20260528.xsd EX-101.SCH 3156
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyra-20260528_lab.xml EX-101.LAB 17976
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyra-20260528_pre.xml EX-101.PRE 11242
14 EXTRACTED XBRL INSTANCE DOCUMENT d33725d8k_htm.xml XML 3629
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 261055755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)